Teva Pharma : “Nice defensive name” for this tough market, Cramer said.
Gushan : This is a speculation play on the return of China, Cramer said. If you can stomach the risk, then buy Gushan.
Atlas Pipeline : Cramer’s bullish on APL. The stock’s been under pressure from hedge-fund selling, but the reduced stock price might offer investors a good opportunity to buy.
Questions for Cramer? madmoney@cnbc.com
Questions, comments, suggestions for the Mad Money website? madcap@cnbc.com